Illumina Inc. (ILMN)

290.50
5.85 2.06
NASDAQ : Health Technology
Prev Close 284.65
Open 285.54
Day Low/High 284.71 / 290.63
52 Wk Low/High 268.62 / 380.76
Volume 505.59K
Avg Volume 1.11M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 42.07B
EPS 5.60
P/E Ratio 45.82
Div & Yield N.A. (N.A)
Illumina Shares Hammered by Sales Forecast Cut

Illumina Shares Hammered by Sales Forecast Cut

Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.

Stock Losses Accelerate as Alcoa Sinks After Earnings Miss

Stock Losses Accelerate as Alcoa Sinks After Earnings Miss

Stocks slip on Tuesday as a disappointing quarterly performance from Alcoa sours optimism over the earnings season.

Illumina (ILMN) Stock Tanks After Lower Q3 Outlook, Downgrades

Illumina (ILMN) Stock Tanks After Lower Q3 Outlook, Downgrades

Illumina (ILMN) cut its third-quarter revenue forecast and was downgraded by Citi and Janney Capital.

Morning Movers: ILMN, STJ, AA, MRO, CHK

Morning Movers: ILMN, STJ, AA, MRO, CHK

Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.

Analysts' Actions -- Encana, Norfolk Southern, Seagate, Tyson and More

Analysts' Actions -- Encana, Norfolk Southern, Seagate, Tyson and More

Here are Tuesday's top research calls, including upgrades for Encana, Norfolk Southern, Seagate and Tyson.

Futures and Oil Gain; Asia Mixed on Samsung's Woes

Futures and Oil Gain; Asia Mixed on Samsung's Woes

Oil is likely to be in focus once again Tuesday after Monday brought no new economics news and little corporate news.

Illumina (ILMN) Stock Plunges in After-Hours Trading, Cuts Q3 Guidance

Illumina (ILMN) Stock Plunges in After-Hours Trading, Cuts Q3 Guidance

Illumina (ILMN) reduced its third-quarter revenue forecast late Monday.

Illumina Announces Preliminary Revenue For Third Quarter Of Fiscal Year 2016

Illumina Announces Preliminary Revenue For Third Quarter Of Fiscal Year 2016

Illumina, Inc. (NASDAQ: ILMN) today announced estimated third quarter revenue of approximately $607 million, a 10% increase compared to $550 million in the third quarter of 2015.

These 5 Biotech Stocks Are Ready for a Volatility Break

These 5 Biotech Stocks Are Ready for a Volatility Break

The squeeze is on these stocks, and they are poised for volatile moves.

Illumina Faces a Bumpy Ride for a Few Quarters

Illumina Faces a Bumpy Ride for a Few Quarters

I have been a big bull on its technology, but I am sidelined right now.

Illumina To Webcast Live Presentation At The Morgan Stanley Global Healthcare Conference

Illumina To Webcast Live Presentation At The Morgan Stanley Global Healthcare Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company's presentation at the Morgan Stanley Global Healthcare Conference in New York, NY, on September 13, 2016.

Illumina Becomes #20 Most Shorted Nasdaq 100 Component, Replacing Charter Communications

Illumina Becomes #20 Most Shorted Nasdaq 100 Component, Replacing Charter Communications

The most recent short interest data has been released for the 08/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina Shares Gain 2%, Cooling Speculation of a Thermo Fisher Buyout

Illumina Shares Gain 2%, Cooling Speculation of a Thermo Fisher Buyout

Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.

Dissecting Thermo Fisher's Possible Illumina Deal

The potential transaction could be a true game-changer that makes sense strategically and financially, albeit dilutive near term.

Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation

Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation

Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).

Illumina And FlowJo, LLC Partner To Develop And Co-Market A Software Solution For Single Cell Genomics

Illumina And FlowJo, LLC Partner To Develop And Co-Market A Software Solution For Single Cell Genomics

Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a partnership to develop and co-market analysis software for single cell next-generation sequencing (NGS) data.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Lots of energy names facing the potential for lower prices.

Illumina Lights Up After Earnings -- Here's How to Trade It Now

Illumina Lights Up After Earnings -- Here's How to Trade It Now

Illumina is in breakout mode and could be headed much higher.

Philip W. Schiller (Photo: Business Wire)

Philip W. Schiller (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W.

The New #31 Most Shorted Nasdaq 100 Component: Illumina

The New #31 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 07/15/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Trade-Ideas: Illumina (ILMN) Is Today's "Water-Logged And Getting Wetter" Stock

Trade-Ideas: Illumina (ILMN) Is Today's "Water-Logged And Getting Wetter" Stock

Trade-Ideas LLC identified Illumina (ILMN) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Trade-Ideas: Illumina (ILMN) Is Today's Post-Market Leader Stock

Trade-Ideas: Illumina (ILMN) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Illumina (ILMN) as a post-market leader candidate

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2016

Illumina Reports Financial Results For Second Quarter Of Fiscal Year 2016

Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of fiscal year 2016.

3 Stocks Pushing The Drugs Industry Downward

3 Stocks Pushing The Drugs Industry Downward

TheStreet highlights 3 stocks pushing the drugs industry lower today.

Insider Trading Alert - AFSI, ILMN And SIG Traded By Insiders

Insider Trading Alert - AFSI, ILMN And SIG Traded By Insiders

Stocks with insider trader activity include AFSI, ILMN and SIG

3 Stocks Pushing The Health Care Sector Lower

3 Stocks Pushing The Health Care Sector Lower

TheStreet highlights 3 stocks pushing the health care sector lower today.

Illumina To Announce Second Quarter 2016 Financial Results On Tuesday, July 26, 2016

Illumina To Announce Second Quarter 2016 Financial Results On Tuesday, July 26, 2016

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for second quarter 2016 following the close of market on Tuesday, July 26, 2016.

Illumina Applauds FDA's Issuance Of Draft Guidances To Advance Precision Medicine Using Next Generation Sequencing

Illumina Applauds FDA's Issuance Of Draft Guidances To Advance Precision Medicine Using Next Generation Sequencing

Illumina, Inc. (NASDAQ: ILMN) today announced that it supports the Food and Drug Administration (FDA) in their efforts to provide a flexible and streamlined approach to the oversight of next generation sequencing (NGS)...

Unusual Social Activity Around Illumina (ILMN) Today

Unusual Social Activity Around Illumina (ILMN) Today

Trade-Ideas LLC identified Illumina (ILMN) as an unusual social activity candidate

Illumina (ILMN) Stock Slumps on Morgan Stanley Downgrade

Illumina (ILMN) Stock Slumps on Morgan Stanley Downgrade

Illumina (ILMN) stock is falling on Tuesday morning after Morgan Stanley cut its rating on shares to ‘underweight’ from ‘equal weight.’

TheStreet Quant Rating: B (Buy)